The EPA has withdrawn a 2020 Roundup cancer risk assessment after determining it could not meet a court deadline to reassess the health risks of the popular weed killer.
A new study links Roundup exposure to an increased risk of convulsions in animals.
A class action lawsuit over the presence of benzene has resulted in a $2.3 million Coppertone sunscreen settlement agreement.
Plaintiffs say it is time to "wind down" the Roundup MDL, or else face indefinite waves of trials in federal courts.
Bayer has agreed to pay $40 million to resolve a whistleblower lawsuit which accused it of kickback schemes and off-label marketing of the drugs Avelox, Baycol and Trasylol.
A Missouri jury has delivered a defense verdict in a recent Roundup non-Hodgkin's lymphoma lawsuit involving multiple plaintiffs.
The EPA says it will be unable to make a court-mandated deadline of October 1 for completing a reassessment of Roundup cancer risks.
A new study finds that Roundup weed killer's active ingredient, glyphosate, passes through the blood-brain barrier, potentially increasing the risk of Alzheimer's and other neurodegenerative diseases.
A new CDC study finds nearly 9-of 10 U.S. children have detectable levels of glyphosate in their blood.
The Appeals Court for the 11th Circuit ruled Bayer and Monsanto can not use federal preemption to avoid a Roundup lawsuit it had already settled.